Loading clinical trials...
Loading clinical trials...
REtrospective, obserVational Study to Describe the Treatment Patterns and Outcomes of Epidermal Growth Factor Receptor Mutant (EGFRm) Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Patients in Belgium
Conditions
Interventions
1L treatment
2L Treatment
+1 more
Locations
15
Belgium
Research Site
Antwerp, Belgium
Research Site
Bouge, Belgium
Research Site
Brussels, Belgium
Research Site
Brussels, Belgium
Research Site
Charleroi, Belgium
Research Site
Edegem, Belgium
Start Date
September 21, 2018
Primary Completion Date
June 19, 2019
Completion Date
June 19, 2019
Last Updated
May 8, 2020
NCT06667908
NCT04165798
NCT06875310
NCT07046923
NCT07222566
NCT06667076
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions